These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29932917)

  • 1. Unfolding of IgG domains detected by non-reducing SDS-PAGE.
    Kirley TL; Norman AB
    Biochem Biophys Res Commun; 2018 Sep; 503(2):944-949. PubMed ID: 29932917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domain unfolding of monoclonal antibody fragments revealed by non-reducing SDS-PAGE.
    Kirley TL; Greis KD; Norman AB
    Biochem Biophys Rep; 2018 Dec; 16():138-144. PubMed ID: 30417132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-domain unfolding of the Fab fragment of a humanized anti-cocaine mAb characterized by non-reducing SDS-PAGE.
    Kirley TL; Norman AB
    Biochem Biophys Res Commun; 2020 Dec; 533(3):580-585. PubMed ID: 32988582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of lower molecular weight artifact bands of recombinant monoclonal IgG1 antibodies on non-reducing SDS-PAGE.
    Liu H; Gaza-Bulseco G; Chumsae C; Newby-Kew A
    Biotechnol Lett; 2007 Nov; 29(11):1611-22. PubMed ID: 17609855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand binding to a humanized anti-cocaine mAb detected by non-reducing SDS-PAGE.
    Kirley TL; Norman AB
    Biochem Biophys Rep; 2020 Sep; 23():100795. PubMed ID: 32817883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel modification to monoclonal antibodies: thioether cross-link of heavy and light chains.
    Tous GI; Wei Z; Feng J; Bilbulian S; Bowen S; Smith J; Strouse R; McGeehan P; Casas-Finet J; Schenerman MA
    Anal Chem; 2005 May; 77(9):2675-82. PubMed ID: 15859580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies.
    Ionescu RM; Vlasak J; Price C; Kirchmeier M
    J Pharm Sci; 2008 Apr; 97(4):1414-26. PubMed ID: 17721938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major cause of antibody artifact bands on non-reducing SDS-PAGE and methods for minimizing artifacts.
    Zhang Y; Wang Y; Li Y
    Protein Expr Purif; 2019 Dec; 164():105459. PubMed ID: 31344475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of monoclonal antibody fragmentation artifacts in non-reducing SDS-PAGE.
    Zhu ZC; Chen Y; Ackerman MS; Wang B; Wu W; Li B; Obenauer-Kutner L; Zhao R; Tao L; Ihnat PM; Liu J; Gandhi RB; Qiu B
    J Pharm Biomed Anal; 2013 Sep; 83():89-95. PubMed ID: 23708435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a CE-SDS shoulder peak as disulfide-linked fragments from common C
    Cao M; Jiao Y; Parthemore C; Korman S; Ma J; Hunter A; Kilby G; Chen X
    MAbs; 2021; 13(1):1981806. PubMed ID: 34719342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of SDS-PAGE and intact mass analysis for rapid determination of heterogeneities in monoclonal antibody therapeutics.
    Yamada H; Matsumura C; Yamada K; Teshima K; Hiroshima T; Kinoshita M; Suzuki S; Kakehi K
    Electrophoresis; 2017 May; 38(9-10):1344-1352. PubMed ID: 28261824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational and Colloidal Stabilities of Isolated Constant Domains of Human Immunoglobulin G and Their Impact on Antibody Aggregation under Acidic Conditions.
    Yageta S; Lauer TM; Trout BL; Honda S
    Mol Pharm; 2015 May; 12(5):1443-55. PubMed ID: 25871775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microheterogeneity of a purified IgG1 due to asymmetric Fab glycosylation.
    Grebenau RC; Goldenberg DM; Chang CH; Koch GA; Gold DV; Kunz A; Hansen HJ
    Mol Immunol; 1992 Jun; 29(6):751-8. PubMed ID: 1603094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of sodium dodecyl sulfate-polyacrylamide gel electrophoresis sample preparation artifacts for analysis of IgG4 half-antibody.
    Taylor FR; Prentice HL; Garber EA; Fajardo HA; Vasilyeva E; Blake Pepinsky R
    Anal Biochem; 2006 Jun; 353(2):204-8. PubMed ID: 16564018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life.
    Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Volkin DB; Weis DD
    MAbs; 2015; 7(1):84-95. PubMed ID: 25524268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonnative aggregation of an IgG1 antibody in acidic conditions: part 1. Unfolding, colloidal interactions, and formation of high-molecular-weight aggregates.
    Brummitt RK; Nesta DP; Chang L; Chase SF; Laue TM; Roberts CJ
    J Pharm Sci; 2011 Jun; 100(6):2087-103. PubMed ID: 21213308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving SDS-PAGE method for monoclonal antibodies: The advantages of Tris-Acetate over Tris-Glycine SDS-PAGE system and comparison with CE-SDS method.
    Sonboli R; Najafi Z; Zarezadeh N; Yazdani M; Behrouz H
    Protein Expr Purif; 2021 Jun; 182():105845. PubMed ID: 33596474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a reduced disulfide bond on aggregation properties of the human IgG1 CH3 domain.
    Sakurai K; Nakahata R; Lee YH; Kardos J; Ikegami T; Goto Y
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1526-35. PubMed ID: 25748879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multistep denaturation and hierarchy of disulfide bond cleavage of a monoclonal antibody.
    Brody T
    Anal Biochem; 1997 May; 247(2):247-56. PubMed ID: 9177685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of monoclonal antibody production in cell culture using novel microfluidic and traditional assays.
    Ohashi R; Otero JM; Chwistek A; Hamel JF
    Electrophoresis; 2002 Oct; 23(20):3623-9. PubMed ID: 12412133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.